Change-scores of the clinical and instrumented secondary outcome measures were compared between groups following the same method used for the primary outcomes (i.e. separate ANCOVA tests with baseline scores as covariates). Moreover, a chi-square test was used to compare the number of clinically improved participants (i.e. post-treatment improvement > = 5 points in FM_UE) between groups. The analyses were performed following a per-protocol approach.